Dermisil

Manufacturer
Nature's Innovation, Inc.
Effective date
2011-10-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:50:32

Label at a glance#

ProductDermisil Warts
Active ingredientTHUJA OCCIDENTALIS LEAFY TWIG
Label structure8 sections

Indications and uses

Uses:   Symptomatic treatment of common warts, verruca vulgaris, plantar's warts and flat warts.

Dosage and administration

Directions:   Apply 3 times daily to affected area. Warts will dry and flake away over a 3-6 week period. Some individuals may be sensitive to essential oils. Skin test for tolerability. If irritation or reaction occurs, discontinue use.

Label contents#

Full prescribing information#

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Drug Facts

Active In
gredients:

Thuja Occidentalis 6X HPUS               

DESCRIPTION SECTION

The letters HPUS indicate the component(s) in this product is (are) officially monographed in the Homeopathic Pharmacopeia of the United States.

Uses

INDICATIONS & USAGE SECTION

Uses:  Symptomatic treatment of common warts, verruca vulgaris, plantar's warts and flat warts.

Warnings

WARNINGS SECTION

Warnings:  For external use only.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if pregnant or nursing.

OTHER SAFETY INFORMATION

Avoid using near eyes or mouth. 

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

OTC - DO NOT USE SECTION

Do not use if tamper evident seal is broken.

OTHER SAFETY INFORMATION

In case of ingestion call Poison Control Center hotline immediately at 1-800-222-1222.

Directions

DOSAGE & ADMINISTRATION SECTION

Directions:  Apply 3 times daily to affected area. Warts will dry and flake away over a 3-6 week period. Some individuals may be sensitive to essential oils. Skin test for tolerability. If irritation or reaction occurs, discontinue use.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Inactive Ingredients: Cedar Leaf Oil, Melaleuca Alternifolia Leaf Oil, Ricinus Communis Seed Oil.

Questions

OTC - QUESTIONS SECTION

Questions? Comments?www.naturasil.com 866.371.2499 Mfd.
by: Nature's Innovation, Inc. 2723 Brickton North Dr., Buford, GA
30518  Not tested on animals.

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

100% Natural Plant Extracts

Naturasil

30ml (1.014 fl.oz.)

Topical Liquid

Homeopathic Medicine

Warts

Image of Warts 30 ml
Image of Warts 30 ml

OTC - PURPOSE SECTION

Purpose

Wart Symptom Relief

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
10893-687-302020-02-04C16284748780-19d75b9d0-00ca-f424-e053-dadaa90a57ceWarts 30 ml Labeling
10893-687-302020-01-31C16284748780-19d75b9d0-00ca-f424-e053-dadaa90a57ceWarts 30 ml Labeling

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
THUJA OCCIDENTALIS LEAFY TWIGACTIVE INGREDIENT1NT28V93971
THUJA OCCIDENTALIS LEAFY TWIGACTIVE MOIETY1NT28V93971
CASTOR OILINACTIVE INGREDIENTD5340Y2I9G1
CEDAR LEAF OILINACTIVE INGREDIENTBJ169U4NLG1
TEA TREE OILINACTIVE INGREDIENTVIF565UC2G1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10893-68710893-687-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 16 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
CASTOR OILCASTOR OILD5340Y2I9GTABLET, EXTENDED RELEASE / ORAL23.27 mgExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GGEL / NASAL429 mgExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GGRANULE, FOR SUSPENSION / ORAL128 mgExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GINJECTION, SOLUTION / INTRAMUSCULAR525 mgExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GTABLET / ORAL17 mgExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GCAPSULE, EXTENDED RELEASE / ORAL47 mgExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GEMULSION / OPHTHALMIC32 mgExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GSPRAY / NASALNAExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GTABLET, FILM COATED / ORAL15.29 mgExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GOINTMENT / TOPICAL14.9 %w/wExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GSOLUTION / TOPICAL1.38 %w/wExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GTABLET, DELAYED RELEASE / ORAL0.01 mgExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GTABLET, COATED / ORAL0.9 mgExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GINJECTION / INTRAMUSCULAR885 mgExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GCAPSULE / ORAL1.04 mgExact identifier — unii candidate
16 equally ranked IID candidates
CASTOR OILCASTOR OILD5340Y2I9GTABLET / SUBLINGUAL1.6 mgExact identifier — unii candidate
16 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
b4427511-4a39-4051-97ff-b7bdc63ca3a8f658153c-95a0-4d2b-8f17-f03b683d71d22011-10-01WarningsExact identifier
spl id: b4427511-4a39-4051-97ff-b7bdc63ca3a8
spl set id: f658153c-95a0-4d2b-8f17-f03b683d71d2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.